PhaseI/II study of Docetaxel/S-1 with radiation for unresectable and/or recurrent esophageal cancer
Phase 1
- Conditions
- unresectyable esophageal cancer, recurrent esophageal cancer
- Registration Number
- JPRN-UMIN000004349
- Lead Sponsor
- Department of Digestive surgery, Kawasaki Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Excluded criteria is follow; 1.the case complicated severe heart failure,liver chirrhosis, uncontrolled diabets, interstitial pneumonia or fibriod lung, pooling of pleural effusion needed treatment and pericardial effusion. 2.the case suspected of infection with feaveer 3.the case had the motion disturbance, peripheral nerve palsy and severe edema 4.the case complicated other active cancer 5.pregnant woman or lactational woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall response
- Secondary Outcome Measures
Name Time Method Overall suevivalsurvival Time to progression toxicity Local conterol rate